Surgnova debuted in The 12th Greek Ablation Exhibition with Dophi™ N3000 Electroporation System, Dophi™ M150E Microwave Ablation System and Dophi™ R150E Radiofrequency Ablation System.

Surgnova continues to explore and lead the development of tumor ablation technology and is committed to providing the most advanced and complete tumor ablation platform worldwide, to achieve precision, diversity and reliability of tumor ablation treatment.